~~<i id='3E8D1CC089'><strike id='3E8D1CC089'><tt id='3E8D1CC089'><pre id='3E8D1CC089'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：fashion 2025-09-30 00:34:32 - browse：343

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Walmart eyes Medicare Advantage provider ChenMed

Wikipedia

focus

hotspot

explore

hotspot

8:30ApartoftheTitanic'sbow,viewedintheAtlanticOcean,northofNewfoundlandin1996.XavierDesmier/Gamma-Ra

WSS

California man arrested in connection with serial murders of Mexican strip club workers

Telehealth for opioid use disorder is lifesaving

Regeneron agrees to White House price limits on anti

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

US intelligence assessment says Iran not currently developing nuclear weapons

focus

entertainment

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Telehealth for opioid use disorder is lifesaving

Psychedelics group wrestles with new pharma identity

Popular nasal decongestant doesn't actually relieve congestion

Supreme Court strikes down use of affirmative action

US intelligence assessment says Iran not currently developing nuclear weapons

Bright Health sells Medicare Advantage business to Molina

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

23andMe had bad news about my health. I wish a person had delivered it

What to know about a major upcoming Wegovy heart health study

focus

A common UTI test for kids haunts adults as a traumatic 'nightmare'

What to make of Biden’s latest efforts on cancer research

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Hospitals consider fixing cancer drug shortages on their own

How corporate America is slashing DEI workers amid backlash to diversity programs

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

hotspot

explore

explore

hotspot